According to Mr. Hosier, the Food and Drug Administration does not actively work to match product indication language found on pharmaceutical labels with diagnosis language in ICD-9 or ICD-10. When indications and diagnoses are not a perfect match, reimbursement for products and services are denied, potentially adversely affecting patient care.
He recommends pharmaceutical companies need to address the need for indication language that can match up with appropriate codes in ICD-10. Coding and payment processes will suffer if existing product labels are unable to be matched with the more specific codes in ICD-10.
Read Mr. Hosier’s article on the GLGroup website.
Read more on coding:
–Tax Credit to Create Coding Jobs in Lansing, Mich.
–MGMA Connexion Debunks Four Common Coding Myths
–Preparing Your Surgery Center for ICD-10: 6 Initial Steps
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.